Cancer and Metastasis Reviews

, Volume 21, Issue 3–4, pp 231–255 | Cite as

Botanicals in Cancer Chemoprevention

  • Eun Jung Park
  • John M. Pezzuto
Article

Abstract

Botanicals have been used for the treatment of various human diseases throughout history. In addition, botanicals play a role in disease prevention. For example, epidemiologic studies have suggested that a reduced risk of cancer is associated with high consumption of vegetables and fruits. Thus, the cancer chemopreventive potential of naturally occurring phytochemicals is of great interest. In this review, we discuss the cancer chemopreventive activity of cruciferous vegetables such as cabbage and broccoli, Allium vegetables such as garlic and onion, green tea, Citrus fruits, tomatoes, berries, ginger and ginseng, as well as some medicinal plants. In addition, methods for the discovery of active compounds from plant sources are described. Several lead compounds, such as brassinin (from cruciferous vegetables like Chinese cabbage), sulforaphane (from broccoli) and its analog sulforamate, withanolides (from tomatillos), and resveratrol (from grapes and peanuts among other foods), are in preclinical or clinical trials for cancer chemoprevention. Phytochemicals of these types have great potential in the fight against human cancer, and a variety of delivery methods are available as a result of their occurrence in nature.

botanical vegetable fruit cancer chemoprevention carcinogenesis bioassay 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Von Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990–1997. JAMA 280: 1569–1575, 1998Google Scholar
  2. 2.
    Go VLW, Wong DA, Resnick MS, Heber D: Evaluation of botanicals and dietary supplements therapy in cancer patients. J Nutr 131: 179S–180S, 2001Google Scholar
  3. 3.
    von Gyuenigen VE, Hopkins MP: Alternative medicine in gynecologic oncology: A case report. Gynecol Oncol 77: 190–192, 2000Google Scholar
  4. 4.
    Pezzuto JM: Plant-derived anticancer agents. Biochem Pharmacol 53: 121–133, 1997Google Scholar
  5. 5.
    Terry P, Giovannucci E, Michels KB, Bergkvist L, Hansen H, Holmberg L, Wolk A: Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst 93: 525–533, 2001Google Scholar
  6. 6.
    van Duyn MAS, Pivonka E: Overview of the health benefits of fruit and vegetable consumption for the dietetics professional: Selected literature. J Am Diet Assoc 100: 1511–1521, 2000Google Scholar
  7. 7.
    Steinmetz KA, Potter JD: Vegetables, fruit and cancer chemoprevention: A review. J Am Diet Assoc 96: 1027–1039, 1996Google Scholar
  8. 8.
    Seow A, Shi CY, Chung FL, Jiao D, Hankin JH, Lee HP, Coetzee GA, Yu MC: Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: Relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol Biomarkers Prev 7: 775–781, 1998Google Scholar
  9. 9.
    Talalay P, Fahey JW: Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131: 3027S–3033S, 2001Google Scholar
  10. 10.
    Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL: Fruit and vegetable intake and incidence of bladder cancer in a male prostate cohort. J Natl Cancer Inst 91: 605–613, 1999Google Scholar
  11. 11.
    Spitz MR, Duphorne CM, Detry MA, Pillow PC, Amos CI, Lei L, de Andrade M, Gu X, Hong WK, Wu X: Dietary intake of isothiocyanates: Evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev 9: 1017–1020, 2000Google Scholar
  12. 12.
    Zhao B, Seow A, Lee EJD, Poh WT, Teh M, Eng P, Wang YT, Tan WC, Yu MC, Lee HP: Dietary isothiocyanates, glutathione S-transferase-M1,-T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 10: 1063–1067, 2001Google Scholar
  13. 13.
    Zhang SM, Hunter DJ, Rosner BA, Giovannucci EL, Colditz GA, Speizer FE, Willett WC: Intakes of fruits, vegetables and related nutrients and the risk of non-Hodgkin's lymphoma among women. Cancer Epidemiol Biomarkers Prev 9: 477–485, 2000Google Scholar
  14. 14.
    Cohen JH, Kristal AR, Stanford JL: Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 92: 61–68, 2000Google Scholar
  15. 15.
    Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RS Jr: Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9: 795–804, 2000Google Scholar
  16. 16.
    Terry P, Wolk A, Persson I, Magnusson C: Brassica vegetables and breast cancer risk. JAMA 285: 2975–2977, 2001Google Scholar
  17. 17.
    Seow A, Zhao B, Lee EJD, Poh WT, Teh M, Eng P, Wang YT, Tan WC, Lee HP: Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: A preliminary study among Chinesewomen in Singapore. Carcinogenesis 22: 673–677, 2001Google Scholar
  18. 18.
    Lin HJ, Probst-Hensch NM, Louie AD, Kau IH, Witte JS, Ingles SA, Frankl HD, Lee ER, Haile RW: Glutathione transferase null genotype broccoli and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 7: 647–652, 1998Google Scholar
  19. 19.
    Hecht SS, Chung FL, Richie JP Jr, Akerkar SA, Borukhova A, Skowronski L, Carmella SG: Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev 4: 877–884, 1995Google Scholar
  20. 20.
    Hecht SS: Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 32: 395–411, 2000Google Scholar
  21. 21.
    Steinkellner H, Rabot S, Freywald C, Nobis E, Scharf G, Chabicovsky M, Knasmüller S, Kassie F: Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat Res 480–481: 285–297, 2001Google Scholar
  22. 22.
    Zhu C, Poulsen HE, Loft S: Inhibition of oxidative DNA damage in vitro by extracts of Brussels sprouts. Free Radic Res 33: 187–196, 2000Google Scholar
  23. 23.
    Vang O, Frandsen H, Hansen KT, Sorensen JN, Sorensen H, Anderson O: Biochemical effects of dietary intakes of different broccoli samples. I. Differential modulation of cytochrome P-450 activates in rat liver, kidney, and colon. Metabolism 50: 1123–1129, 2001Google Scholar
  24. 24.
    Brooks JD, Paton VG, Vidanes G: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev 10: 949–954, 2001Google Scholar
  25. 25.
    Clapper ML, Szarka CE, Pfeiffer GR, Graham TA, Balshem AM, Litwin S, Goosenberg EB, Frucht H, Engstrom PF: Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity. Clin Cancer Res 2: 25–30, 1997Google Scholar
  26. 26.
    Bogaards JJ, van Ommen B, Falke HE, Willems MI, van Bladeren PJ: Glutathione S-transferase subunit induction patterns of Brussels sprouts, allyl isothiocyanates and goitrin in rat liver and small intestinal mucosa: A new approach for the identification of inducing xenobiotics. Food Chem Toxicol 28: 81–88, 1990Google Scholar
  27. 27.
    Chung FL, Conaway CC, Rao CV, Reddy BS: Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 21: 2287–2291, 2000Google Scholar
  28. 28.
    Bonnesen C, Eggleston IM, Hayes JD: Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61: 6120–6130, 2001Google Scholar
  29. 29.
    Bradlow HL, Sepkovic DW, Telang NT, Osborne MP: Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent. Ann N Acad Sci 889: 204–213, 1999Google Scholar
  30. 30.
    Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P: Human metabolism and excretion of cancer chemopreventive glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol Biomarkers Prev 7: 1091–1100, 1998Google Scholar
  31. 31.
    Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P: Chemopreventive glucosinolates and isothiocyanates of broccoli sprouts: Metabolism and excretion in humans. Cancer Epidemiol Biomarkers Prev 10: 501–508, 2001Google Scholar
  32. 32.
    Murray S, Lake BG, Gray S, Edwards AJ, Springall C, Bowey EA, Williamson G, Boobis AR, Gooderham NJ: Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man. Carcinogenesis 22: 1413–1420, 2001Google Scholar
  33. 33.
    Kensler TW, Curphey TJ, Maxiutenko Y, Roebuck BD: Chemoprevention by organosulfur inducers of phase II enzymes: Dithiolethiones and dithiins. Drug Metabol Drug Interact 17: 3–22, 2000Google Scholar
  34. 34.
    Yuan JM, Gago-Dominguez M, Castelao JE, Hankin JH, Ross RK, Yu MC: Cruciferous vegetables in relation to renal cell carcinoma. Int J Cancer 77: 211–216, 1998Google Scholar
  35. 35.
    Rivlin RS: Historical perspective on the use of garlic. J Nutr 131: 951S–954S, 2001Google Scholar
  36. 36.
    Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y: Intake of garlic and its bioactive components. J Nutr 131: 955S–962S, 2001Google Scholar
  37. 37.
    Ide N, Lau BHS: Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-κB activation. J Nutr 131: 1020S–1026S, 2001Google Scholar
  38. 38.
    Lau BHS: Suppression of LDL oxidation by garlic. J Nutr 131: 985S–988S, 2001Google Scholar
  39. 39.
    Yeh YY, Liu L: Cholesterol-lowering effect of garlic extracts and organosulfur compounds: Human and animal studies. J Nutr 131: 989S–993S, 2001Google Scholar
  40. 40.
    Fleischauer AT, Arab L: Garlic and cancer: A critical review of the epidemiologic literature. J Nutr 131: 1032S–1040S, 2001Google Scholar
  41. 41.
    Dorant E, van den Brandt PA, Goldbohm RA: A prospective cohort study on Allium vegetable consumption, garlic supplement use, and the risk of lung carcinoma in the Netherlands. Cancer Res 54: 6148–6153, 1994Google Scholar
  42. 42.
    Dorant E, van den Brandt PA, Goldbohm RA: A prospective cohort study on the relationship between onion and leek consumption, garlic supplement use and the risk of colorectal carcinoma in the Netherlands. Carcinogenesis 17: 477–484, 1996Google Scholar
  43. 43.
    Fleischauer AT, Poole C, Arab L: Garlic consumption and cancer prevention: Meta-analyses of colorectal and stomach cancers. Am J Clin Nutr 72: 1047–1052, 2000Google Scholar
  44. 44.
    Takezaki T, Gao CM, Ding JH, Liu TK, Li MS, Tajima K: Comparative study of lifestyles of residents in high and low risk areas for gastric cancer in Jiangsu Province, China; with special reference to allium vegetables. J Epidemiol 9: 297–305, 1999Google Scholar
  45. 45.
    Muñoz N, Plummer M, Vivas J, Moreno V, de Sanjose S, Lopez G, Oliver W: A case-control study of gastric cancer in Venezuela. Int J Cancer 93: 417–423, 2001Google Scholar
  46. 46.
    Sivam GP: Protection against Helicobacter pylori and other bacterial infections by garlic. J Nutr 131: 1106S–1108S, 2001Google Scholar
  47. 47.
    Sparnins VL, Barany G, Wattenberg LW: Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis 9: 131–134, 1988Google Scholar
  48. 48.
    Wargovich MJ, Woods C, Eng VW, Stephens LC, Gray K: Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Res 48: 6872–6875, 1988Google Scholar
  49. 49.
    Wargovich MJ: Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis 8: 487–489, 1987Google Scholar
  50. 50.
    Wattenberg LW, Sparnins VL, Barany G: Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes. Cancer Res 49: 2689–2692, 1989Google Scholar
  51. 51.
    Fukushima S, Takada N, Hori T, Wanibuchi H: Cancer prevention by organosulfur compounds from garlic and onion. J Cell Biochem 27 (Suppl.): 100–105, 1997Google Scholar
  52. 52.
    Milner JA: Historical perspective on garlic and cancer. J Nutr 131: 1027S–1031S, 2001Google Scholar
  53. 53.
    Robert V, Mouillé B, Mayeur C, Michaud M, Blanchier F: Effects of the garlic compound diallyl disulfide on the metabolism, adherence and cell cycle of HT-29 colon carcinoma cells: Evidence of sensitive and resistant subpopulations. Carcinogenesis 22: 1155–1161, 2001Google Scholar
  54. 54.
    Shirin H, Pinto JT, Kawabata Y, Soh JW, Delohery T, Moss SF, Murty V, Rivlin RS, Holt PR, Weinstein IB: Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer Res 61: 725–731, 2001Google Scholar
  55. 55.
    Singh SV, Pan SS, Srivastava SK, Xia H, Hu X, Zaren HA, Orchard JL: Differential induction of NAD(P)H: Quinone oxidoreductase by anti-carcinogenic organosulfides from garlic. Biochem Biophys Res Commun 244: 917–920, 1998Google Scholar
  56. 56.
    Dion ME, Agler M, Milner JA: S-Allyl cysteine inhibits nitromorpholine formation and bioactivation. Nutr Cancer 28: 1–6, 1997Google Scholar
  57. 57.
    Ip C, Lisk DJ; Enrichment of selenium in allium vegetables for cancer prevention. Carcinogenesis 15: 1881–1885, 1994Google Scholar
  58. 58.
    el-Bayoumy K, Chae YH, Upadhyaya P, Ip C: Chemoprevention of mammary cancer by diallyl selenide, a novel organoselenium compound. Anticancer Res 16: 2911–2915, 1996Google Scholar
  59. 59.
    Dong Y, Lisk D, Block E, Ip C: Characterization of the biological activity of γ-glutamyl-selenium-methylselenocysteine: A novel, naturally occurring anticancer agent from garlic. Cancer Res 61: 2923–2928, 2001Google Scholar
  60. 60.
    Tuyns AJ: Protective effect of citrus fruit on esophageal cancer. Nutr Cancer 5: 195–200, 1983Google Scholar
  61. 61.
    Bosetti C, La Vecchia C, Talamini R, Simonato L, Zambon P, Negri E, Trichopoulos D, Lagiou P, Bardini R, Franceschi S: Food groups and risk of squamous cell esophageal cancer in northern Italy. Int J Cancer 87: 289–294, 2000Google Scholar
  62. 62.
    Launoy G, Milan C, Day NE, Pienkowski MP, Gignoux M, Faivre J: Diet and squamous-cell cancer of the oesophagus: A French multicentre case-control study. Int J Cancer 76: 7–12, 1998Google Scholar
  63. 63.
    Nyberg F, Agrenius V, Svartengren K, Svensson C, Pershagen G: Dietary factors and risk of lung cancer in never-smokers. Int J Cancer 78: 430–436, 1998Google Scholar
  64. 64.
    Botterweck AA, van den Brandt PA, Goldbohm RA: A prospective cohort study on vegetable and fruit consumption and stomach cancer risk in the Netherlands. Am J Epidemiol 148: 842–853, 1998Google Scholar
  65. 65.
    Boeing H, Frentzel-Beyme R, Berger M, Berndt V, Gores W, Korner M, Lohmeier R, Menarcher A, Mannl HF, Meinhardt M, Mannl HF, Meinhardt M: Case-control study on stomach cancer in Germany. Int J Cancer 47: 858–864, 1991Google Scholar
  66. 66.
    Ramon JM, Serra L, Cerdo C, Oromi J: Dietary factors and gastric cancer risk, A case-control study in Spain. Cancer 71: 1731–1735, 1993Google Scholar
  67. 67.
    Franceschi S, Levi F, Negri E, Fassina A, La Vecchia C: Diet and thyroid cancer: A pooled analysis of four European case-control studies. Int J Cancer 48: 395–398, 1991Google Scholar
  68. 68.
    Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA: Vegetable and fruit consumption and prostate cancer risk: A cohort study in the Netherlands. Cancer Epidemiol Biomarkers Prev 7: 673–680, 1998Google Scholar
  69. 69.
    Lindblad P, Wolk A, Bergstrom R, Adami HO: Diet and risk of renal cell cancer: A population-based case-control study. Cancer Epidemiol Biomarkers Prev 6: 215–223, 1997Google Scholar
  70. 70.
    Olsen GW, Mandel JS, Gibson RW, Wattenberg LW, Schuman LM: Nutrients and pancreatic cancer: A population-based case-control study. Cancer Causes Control 2: 291–297, 1991Google Scholar
  71. 71.
    Hakim IA, Harris RB, Ritenbaugh C: Citrus peel use is associated with reduced risk of squamous cell carcinoma of the skin. Nutr Cancer 37: 161–168, 2000Google Scholar
  72. 72.
    Murakami A, Nakamura Y, Torikai k, Tanaka T, Koshiba T, Koshimizu K, Kuwahara S, Takahashi Y, Ogawa K, Yano M, Tokuda H, Nishino, H, Mimaki Y, Sashida Y, Kitanaka S, Ohigashi H: Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 60: 5059–5066, 2000Google Scholar
  73. 73.
    Iwase Y, Takemura Y, Ju-ichi M, Yano M, Ito C, Furukawa H, Mukainaka T, Kuchide M, Tokuda H, Nishino H: Cancer chemopreventive activity of 3,5,6,7,8,3´,4´-heptamethyoxyflavone from the peel of citrus plants. Cancer Lett 163: 7–9, 2001Google Scholar
  74. 74.
    Tanaka T, Kohno H, Murakami M, Shimada R, Kagami S, Sumida T, Azuma Y, Ogawa H: Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in β-cryptoxanthin and hesperidin. Int J Cancer 88: 146–150, 2000Google Scholar
  75. 75.
    Kohno H, Taima M, Sumida T, Azuma Y, Ogawa H, Tanaka T: Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett 174: 141–150, 2001Google Scholar
  76. 76.
    Tanaka T, Kawabata K, Kakumoto M, Hara A, Murakami A, Kuki W, Takahashi Y, Yonei H, Maeda M, Ota T, Odashima S, Yamane T, Koshimizu K, Ohigashi H: Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: The inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drugmetabolizing enzymes. Cancer Res 58: 2550–2556, 1998Google Scholar
  77. 77.
    Tanaka T, Kohno H, Murakami M, Kagami S, El-Bayoumy K: Suppressing effects of dietary supplementation of the organoselenium 1,4-phenylenebis(methylene)selenocyanate and the Citrus antioxidant auraptene on lung metastasis of melanoma cells in mice. Cancer Res 60: 3713–3716, 2000Google Scholar
  78. 78.
    Murakami A, Nakamura Y, Tanaka T, Kawabata K, Takahashi D, Koshimizu K, Ohigashi H: Suppression by citrus auraptene of phorbol ester-and endotoxin-induced inflammatory responses: Role of attenuation of leukocyte activation. Carcinogenesis 21: 1843–1850, 2000Google Scholar
  79. 79.
    Murakami A, Wada K, Ueda N, Sasaki K, Haga M, Kuki W, Takahashi Y, Yonei H, Koshimizu K, Ohigashi H: In vitro absorption and metabolism of a citrus chemopreventive agent, auraptene, and its modifying effects on xenobiotic enzyme activities in mouse livers. Nutr Cancer 36: 191–199, 2000Google Scholar
  80. 80.
    Lam LK, Hasegawa S: Inhibition of benzo[a]pyrene-induced forestomach neoplasia in mice by citrus limonoids, Nutr Cancer 12: 43–47, 1989Google Scholar
  81. 81.
    Miller EG, Fanous R, Rivera-Hidalgo F, Binnie WH, Hasegawa S, Lam LK: The effect of citrus limonoids on hamster buccal pouch carcinogenesis. Carcinogenesis 10: 1535–1537, 1989Google Scholar
  82. 82.
    Tanaka T, Maeda M, Kohno H, Murakami M, Kagami S, Miyake M, Wada K: Inhibition of azoxymethane-induced colon carcinogenesis in mice F344 rats by the citrus limonoids obacunone and limonin. Carinogenesis 22: 193–198, 2000Google Scholar
  83. 83.
    Hayashi A, Gillen AC, Lott JR: Effects of daily oral administration of quercetin chalcone and modified citrus pectin. Altern Med Rev 5: 546–552, 2000Google Scholar
  84. 84.
    Hsieh TC, Wu JM: Changes in cell growth, cyclin/kinase, endogenous phosphoproteins and nm23 gene expression in human prostatic JCA-1 cells treated with modified citrus pectin. Biochem Mol Biol Int 37: 833–841, 1995Google Scholar
  85. 85.
    Platt D, Raz A: Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Natl Cancer Inst 84: 438–442, 1992Google Scholar
  86. 86.
    Pienta K, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J, Donat TL, Tait L, Hogan V, Raz A: Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst 87: 348–353, 1995Google Scholar
  87. 87.
    Imai K, Litt D, Suga K, Nakachi K: Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 26: 769–775, 1997Google Scholar
  88. 88.
    Bushman JL: Green tea and cancer in humans: A review of the literature. Nutr Cancer 31: 151–159, 1998Google Scholar
  89. 89.
    Goldbohm RA, Hertog MG, Brants HA, van Poppel G, van den Brandt PA: Consumption of black tea and cancer risk: A prospective cohort study. J Natl Cancer Inst 88: 93–100, 1996Google Scholar
  90. 90.
    Heilbrun LK, Nomura A, Stemmermann GN: Black tea consumption and cancer risk: A prospective study. Br J Cancer 54: 677–683, 1986Google Scholar
  91. 91.
    Zhong L, Goldberg MS, Gao YT, Hanley JA, Parent MI ME, Jin F: A population based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology 12: 695–700, 2001Google Scholar
  92. 92.
    Setiawan VW, Zhang Z-F, Yu G-P, Lu Q-Y, Li Y-L, Lu M-L, Wang M-R, Guo CH, Yu S-Z, Kurtz RC, Hsieh C-C: Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer 92: 600–604, 2001Google Scholar
  93. 93.
    Inoue M, Tajima, K, Mizutani M, Iwata H, Iwase T, Miura S, Hirose K, Hamajima N, Tominaga S: Regular consumption of green tea and the risk of breast cancer recurrence: Follow-up study from the hospital-based epidemiologic research program at Aichi cancer center (HERPACC), Japan. Cancer Lett 167: 175–182, 2001Google Scholar
  94. 94.
    Khan SG, Katiyar SK, Agarwal R, Mukhtar H: Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: Possible role in cancer chemoprevention. Cancer Res 52: 4050–4052, 1992Google Scholar
  95. 95.
    Dong Z, Ma W, Huang C, Yang CS: Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (—)-epigallocatechin gallate, and theaflavins. Cancer Res 57: 4414–4419, 1997Google Scholar
  96. 96.
    Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H: Prostate cancer chemoprevention by green tea: In vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res 59: 2115–2120, 1999Google Scholar
  97. 97.
    Katiyar SK, Afaq F, Perez A, Mukhtar H: Green tea polyphenol (—)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 22: 287–294, 2001Google Scholar
  98. 98.
    Fujiki H, Suganuma M, Okabe S, Sueoka E, Sueoka N, Fujimoto N, Goto Y, Matsuyama S, Imai K, Nakachi K: Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat Res 480–481: 299–304, 2001Google Scholar
  99. 99.
    Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS: Molecular mechanism underlying chemopreventive activities of anti-inflammatory phytochemicals: Downregulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 480–481: 243–268, 2001Google Scholar
  100. 100.
    Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895–2900, 2001Google Scholar
  101. 101.
    Lee E, Park KK, Lee JM, Chun KS, Kang JY, Lee SS, Surh YJ: Suppression of mouse skin tumor promotion and induction of apoptosis in HL-60 cells by Alpinia oxyphilla Miquel (Zingiberaceae). Carcinogenesis 8: 1377–1381, 1998Google Scholar
  102. 102.
    Chun KS, Sohn Y, Kim HS, Kim OH, Park KK, Lee JM, Lee J, Lee JY, Moon A, Lee SS, Surh YJ: Anti-tumor promoting potential of naturally occurring diarylhepatanoids structurally related to curcumin. Mutat Res 428: 49–57, 1999Google Scholar
  103. 103.
    Katiyar SK, Agarwal R, Mukhtar H: Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res 56: 1023–1030, 1996Google Scholar
  104. 104.
    Lee E, Surh YJ: Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett 134: 163–168, 1998Google Scholar
  105. 105.
    Carlton PS, Kresty LA, Siglin JC, Morse MA, Lu J, Morgan C, Stoner GD: Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis 22: 441–446, 2001Google Scholar
  106. 106.
    Kresty LA, Morse MA, Morgan C, Carlton PS, Lu J, Gupta A, Blackwood M, Stoner GD: Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized raspberries. Cancer Res 61: 6112–6119, 2001Google Scholar
  107. 107.
    Xue H, Aziz RM, Sun N, Cassady JM, Kamendulis LM, Xu Y, Stoner GD, Klaunig JE: Inhibition of cellular transformation by berry extracts. Carcinogenesis 22: 351–356, 2001Google Scholar
  108. 108.
    Lee S-J, Ko W-G, Kim J-H, Sung J-H, Lee S-J, Moon C-K, Lee B-H: Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem Pharmacol 60: 677–685, 2000Google Scholar
  109. 109.
    Xiaoguang C, Hongyan L, Xiaohong L, Zhaodi F, Yan L, Lihua T, Rui H: Cancer chemopreventive and therapeutic activities of red ginseng. J Ethnopharmacol 60: 71–78, 1998Google Scholar
  110. 110.
    Shin HR, Kim JY, Yun TK, Morgan G, Vainio H: The cancer-preventive potential of Panax ginseng: A review of human and experimental evidence. Cancer Causes Control 11: 565–576, 2000Google Scholar
  111. 111.
    Albertsson M, Seiving B: Adverse effects of ginseng. No cure in breast cancer. Lakartidningen 93: 2670–2672, 1996Google Scholar
  112. 112.
    Liu J, Burdette JE, Xu H, Gu C, van Breemen RB, Bhat KPL, Booth N, Constantinou AI, Pezzuto JM, Fong HHS, Farnsworth NR, Bolton JL: Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 49: 2472–2479, 2001Google Scholar
  113. 113.
    Giovannucci E: Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature. J Natl Caner Inst 91: 317–331, 1999Google Scholar
  114. 114.
    Rehman A, Bourne LC, Halliwell B, Rice-Evans CA: Tomato consumption modulates oxidative DNA damage in humans. Biochem Biophys Res Commun 262: 828–831, 1999Google Scholar
  115. 115.
    Khachik F, Beecher GR, Smith JC Jr: Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J Cell Biochem 22 (Suppl.): 236–246, 1995Google Scholar
  116. 116.
    Gann PH, Ma J, Giovannucci E, Wilett W, Sacks FM, Hennekens CH, Stampfer MJ: Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cancer Res 59: 1225–1230, 1999Google Scholar
  117. 117.
    Tepsuwan A, Kupradinun P, Kusamran WR: Effect of Siamese cassia leaves on the activities of chemical carcinogen metabolizing enzymes and on mammary gland carcinogenesis in the rat. Mutat Res 428: 363–373, 1999Google Scholar
  118. 118.
    Liu G, Bode A, Ma W-Y, Sang S, Ho C-T, Dong Z: Two novel glycosides from the fruits of Morinda citrifolia (Noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res 61: 5749–5756, 2001Google Scholar
  119. 119.
    Kapadia G, Tokuda H, Konoshima T, Nishino H: Chemoprevention of lung and skin cancer by Beta vulgaris (beet) root extract. Cancer Lett 100: 211–214, 1996Google Scholar
  120. 120.
    Singh A, Singh SP, Bamezai R: Momordica charantia (bitter gourd) peel pulp, seed and whole fruit extract inhibits mouse skin papillomagenesis. Toxicol Lett 94: 37–46, 1998Google Scholar
  121. 121.
    Suaeyun R, Kinouchi T, Arimochi H, Vinitketkummnuen U, Ohnish Y: Inhibitory effects of lemon grass (Cymbopogon citrates Stapf) on formation of azoxymethane-induced DNA adducts and aberrant crypt foci in the rat colon. Carcinogenesis 18: 949–955, 1997Google Scholar
  122. 122.
    Tsunoda S, Yamamoto K, Sakamoto S, Inoue H, Nagasawa H: Effects of Sasa Health, extract of bamboo grass leaves, on spontaneous mammary tumorigenesis in SHN mice. Anticancer Res 18: 153–158, 1998Google Scholar
  123. 123.
    Lee D, Bhat KP, Fong HHS, Farnsworth NR, Pezzuto JM, Kinghorn AD: Aromatase inhibitors from Broussonetia papyrifera. J Nat Prod 64: 1286–1293, 2001Google Scholar
  124. 124.
    Mata-Greenwood E, Ito A, Westenburg H, Cui B, Mehta MG, Kinghorn AD, Pezzuto JM: Discovery of novel inducers of cellular differentiation using HL-60 promyelocytic cells. Anticancer Res 21: 1763–1770, 2001Google Scholar
  125. 125.
    Chang LC, Gills JJ, Bhat KP, Luyengi L, Farnsworth NR, Pezzuto JM, Kinghorn AD: Activity-guided isolation of constituents of Cerbera manghas with antiproliferative and antiestrogenic activities. Bioorg Med Chem Lett 10: 2431–2434, 2000Google Scholar
  126. 126.
    Westenburg HE, Lee KJ, Lee SK, Fong HHS, van Breemen RB, Pezzuto JM, Kinghorn AD: Activity-guided isolation of antioxidative constituents of Cotinus coggygria. J Nat Prod 63: 1696–1698, 2000Google Scholar
  127. 127.
    Gu J-Q, Park EJ, Hawthorne M, Mehta RG, Farnsworth NR, Pezzuto JM, Kinghorn AD: Constituents of Eugenia sandwicensis with potential cancer chemopreventive activity. Phytochemistry 58: 121–127, 2001Google Scholar
  128. 128.
    Jeong HJ, Chang C, Kim HK, Kim IH, Kinghorn AD, Pezzuto JM: Aromatase inhibitors form Isodon excisus var coreanus. Arch Pharm Res 23: 243–245, 2000Google Scholar
  129. 129.
    Kennelly EJ, Gerhäuser C, Song LL, Graham JG, Beecher CWW, Pezzuto JM, Kinghorn AD: Induction of quinone reductase by withanolides isolated from Physalis philadelphica (Tomatillos). J Agric Food Chem 45: 3771–3777, 1997Google Scholar
  130. 130.
    Su B-N, Misico R, Park EJ, Santarsiero BD, Mesecar AD, Fong HHS, Pezzuto JM, Kinghorn AD: Isolation and characterization of potential cancer chemopreventive principles of the leaves and stems of Physalis philadelphica. Tetradedron 58: 3453–3466, 2002Google Scholar
  131. 131.
    Chang LC, Gerhäuser C, Song LL, Farnsworth NR, Pezzuto JM, Kinghorn AD: Activity-guided isolation of constituents of Tephrosia purpurea with the potential to induce the phase II enzyme, quinone reductase. J Nat Prod 60: 869–873, 1997Google Scholar
  132. 132.
    Chang LC, Song LL, Park EJ, Luyengi L, Lee KJ, Farnsworth NR, Pezzuto JM, Kinghorn AD: Bioactive constituents of Thuja occidentalis. J Nat Prod 63: 1235–1238, 2000Google Scholar
  133. 133.
    Takasaki M, Tokuda H, Nishino H, Konoshima T: Cancer chemopreventive agents (antitumor-promoters) form Ajuga decumbens. J Nat Prod 62: 972–975, 1999Google Scholar
  134. 134.
    Konoshima T, Takasaki M, Tokuda H, Nishino H: Cancer preventive activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens. Cancer Lett 157: 87–92, 2000Google Scholar
  135. 135.
    Kim HS, Kacew S, Lee BM: In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis Miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis 20: 1637–1640, 1999Google Scholar
  136. 136.
    Kim HS, Lee BM: Inhibition of benzo[a]pyrene-DNA adduct formation by Aloe barbadensis Miler. Carcinogenesis 18: 771–776, 1997Google Scholar
  137. 137.
    Zheng GQ, Kenney PM, Zhang J, Lam LK: Chemopreventive of benzo[a]pyrene-induced forestomach cancer in mice by natural phthalides from celery seed oil. Nutr Cancer 19: 77–86, 1993Google Scholar
  138. 138.
    Ahmed S, Rahman A, Mathur M, Athar M, Sultana S: Anti-tumor promoting activity of Asteracantha longifolia against experimental hepatocarcinogenesis in rats. Food Chem Toxicol 39: 19–28, 2001Google Scholar
  139. 139.
    Yu L, Yu T, Ma R: Inhibition of the tumor promoting action of 12-O-tetradecanoylphorbol-13-acetate by tubeimoside III isolated from Bolbostemma paniculatum. Carcinogenesis 16: 3045–3048, 1995Google Scholar
  140. 140.
    Itoigawa M, Ito C, Tan HT-W, Kuchide M, Tokuda H, Nishino H, Furukawa H: Cancer preventive agents, 4-phenylcoumarins from Calophyllum inophyllum. Cancer Lett 169: 15–19, 2001Google Scholar
  141. 141.
    Kim DJ, Ahn B, Han BS, Tsuda H: Potential preventive effects of Chelidonium majis L. (Papaveraceae) herb extract on glandular stomach tumor development in rats treated with N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) and hypertonic sodium chloride. Cancer Lett 112: 203–208, 1997Google Scholar
  142. 142.
    Ito H, Miyake M, Nishitani E, Mori K, Hatano T, Okuda T, Konoshima T, Takasaki M, Kozuka M, Mukainaka T, Tokuda H, Nishino H, Yoshida T: Anti-tumor promoting activity of polyphenols from Cowania mexicana and Coleogyne ramosissima. Cancer Lett 143: 5–13, 1999Google Scholar
  143. 143.
    Fukutake M, Yokota S, Kawamura H, Iizuke A, Amagaya S, Fukuda K, Komatsu Y: Inhibitory effect of Coptidis Rhizoma and Scutellariae Radix on azoxymethane-induced aberrant crypt foci formation in rat colon. Biol Pharm Bull 21: 814–817, 1998Google Scholar
  144. 144.
    Takasaki M, Konoshima T, Etoh H, Singh IP, Tokuda H, Nishino, H: Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis. Cancer Lett 155: 61–65, 2000Google Scholar
  145. 145.
    Takasaki M, Konoshima T, Kozuka M, Tokuda H: Anti-tumor-promoting activities of euglobals from Eucalyptus plants. Biol Pharm Bull 18: 435–438, 1995Google Scholar
  146. 146.
    Saleem M, Alam A, Sultana S: Asafoetida inhibits early events of carcinogenesis: A chemopreventive study. Life Sci 68: 1913–1921, 2001Google Scholar
  147. 147.
    Lee JM, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ, Surh YJ: Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res 15: 245–249, 2001Google Scholar
  148. 148.
    Chewonarin T, Kinouchi T, Kataoka K, Arimochi H, Kuwahara T, Vinitketkumnuen U, Ohnishi, Y: Effects of reselle (Hibiscus sabdariffa Linn.), a Thai medicinal plant, on the mutagenicity of various known mutagens in Salmonella typhimurium and on formation of aberrant crypt foci induced by the colon carcinogens azoxymethane and 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine in F344 rats. Food Chem Toxicol 37: 591–601, 1999Google Scholar
  149. 149.
    Banerjee S, Prashar R, Kumar A, Rao AR: Modulatory influence of alcoholic extract of Ocimum leaves on carcinogen-metabolizing enzyme activities and reduced glutathione levels in mouse. Nutr Cancer 25: 205–217, 1996Google Scholar
  150. 150.
    Rajeshkumar NV, Kuttan R: Protective effect of picroliv, the active constituent of Picrorhiza kurroa, against chemical carcinogenesis in mice. Teratog Carcinog Mutagen 21: 303–313, 2001Google Scholar
  151. 151.
    Premalatha B, Sachdanandam P: Semecarpus anacardium L. nut extract administration induces the in vivo antioxidant defense system in aflatoxin B1 mediated hepatocellular carcinoma. J Ethnopharmacol 66: 131–139, 1999Google Scholar
  152. 152.
    Takasaki M, Konoshima T, Tokuda H, Masuda K, Arai Y, Shiojima K, Ageta H: Anti-carcinogenic activity of Taraxacum plant I. Biol Pharm Bull 22: 602–605, 1999Google Scholar
  153. 153.
    Konoshima T, Takasaki M, Kozuka M, Tokuda H, Nishino H, Matsuda E, Nagai M: Anti-tumor promoting activities of isoflavonoids from Wistaria brachybotrys. Biol Pharm Bull 20: 865–868, 1997Google Scholar
  154. 154.
    Minguzzi S, Barata LES, Shin YG, Jonas PF, Chai HB, Park EJ, Pezzuto JM, Cordell GA: Cytotoxic withanolides from Acnistus arborescens. Phytochemistry 59: 635–641, 2002Google Scholar
  155. 155.
    Lee D, Cuendet M, Vigo JS, Graham JG, Cabieses F, Fong HH, Pezzuto JM, Kinghorn AD: A novel cyclooxygenase-inhibitory stilbenolignan from the seeds of Alphanes aculeate. Org Lett 3: 2169–2171, 2001Google Scholar
  156. 156.
    Lee D, Park EJ, Cuendet M, Axelrod F, Chavez PI, Fong HHS, Pezzuto JM, Kinghorn AD: Cyclooxygenase-inhibitory and antioxidant constituents of the aerial parts of Antirhea acutata. Bioorgan Med Chem Lett 11: 1565–1568, 2001Google Scholar
  157. 157.
    Gerhäuser C, Lee SK, Kosmeder JW, Moriarty RM, Hamel E, Mehta RG, Moon RC, Pezzuto JM: Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent. Cancer Res 57: 3429–3435, 1997Google Scholar
  158. 158.
    Su B-N, Chang LC, Park EJ, Cuendet M, Santarsiero BD, Mesecar AD, Mehta RG, Fong HHS, Pezzuto JM, Kinghorn AD: Bioactive constituents of the seeds of Brucea javanica. Planta Med 68: 1–4, 2002Google Scholar
  159. 159.
    Luyengi L, Suh N, Fong HH, Pezzuto JM, Kinghorn AD: A lignan and four terpenoids from Brucea javanica that induce differentiation with cultured HL-60 promyelocytic leukemia cells. Phytochemistry 43: 409–412, 1996Google Scholar
  160. 160.
    Chung HS, Chang LC, Lee SK, Shamon LA, van Breemen RB, Mehta RG, Farnsworth NR, Pezzuto JM, Kinghorn AD: Flavonoid constituents of Chorizanthe diffusa with potential cancer chemopreventive activity. J Agric Food Chem 47: 36–41, 1999Google Scholar
  161. 161.
    Gamez EJ, Luyengi L, Lee SK, Zhu LF, Zhou BN, Fong HHS, Pezzuto JM, Kinghorn AD: Antioxidant flavonoids glycosides from Daphniphyllum calycinum. J Nat Prod 61: 706–708, 1998Google Scholar
  162. 162.
    Udeani GO, Gerhäuser C, Thomas CF, Moon RC, Kosmeder JW, Kinghorn AD, Moriarty RM, Pezzuto JM: Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer Res 57: 3424–3428, 1997Google Scholar
  163. 163.
    Gerhäuser C, You M, Liu J, Moriaty RM, Hawthorne M, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventive potential of sulforamate, a novel analog of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res 57: 272–278, 1997Google Scholar
  164. 164.
    Lee SK, Luyengi L, Gerhäuser C, Mar W, Lee K, Mehta RG, Kinghorn AD, Pezzuto JM: Inhibitory effect of munetone, an isoflavonoid, on 12-O-tetradecanoylphorbol 13-acetate-induced ornithine decarboxylase activity. Cancer Lett 136: 59–65, 1999Google Scholar
  165. 165.
    Chang LC, Bhat KP, Pisha E, Kennelly EJ, Fong HHS, Pezzuto JM, Kinghorn AD: Activity-guided isolation of steroidal alkaloid antiestrogen-binding site inhibitors from Pachysandra procumbens. J Nat Prod 61: 1257–1262, 1998Google Scholar
  166. 166.
    Pezzuto JM, Song LL, Lee SK, Shamon LA, Mata-Greenwood E, Jang M, Jeong HJ, Pisha E, Mehta RG, Kinghorn AD: Bioassay methods useful for activity-guided isolation of natural product cancer chemopreventive agents. In: Hostettmann K, Gupta MP, Marston A (eds) Chemistry, biological and pharmacological properties of medicinal plants from the Americas: Proceedings of the IOCD/CYTED symposium, Panama City, Panama, 23–26 February 1997. Harwood Academic Publ, Australia, 1999, pp 81–110Google Scholar
  167. 167.
    Mehta RG, Liu J, Constantinou A, Thomas CF, Hawthorne M, You M, Gerhäuser C, Pezzuto PM, Moon RC, Moriarty RM: Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis 16: 399–404, 1995Google Scholar
  168. 168.
    Song LL, Kosmeder JW, Lee SK, Gerhäuser C, Lantivit D, Moon RC, Moriarty RM, Pezzuto JM: Cancer chemopreventive activity mediated by 4′-bromoflavone, a potent inducer of phase II detoxification enzymes. Cancer Res 59: 578–585, 1999Google Scholar
  169. 169.
    Bhat KPL, Kosmeder II JW, Pezzuto JM: Biological effects of resveratrol. Antiox Redox Signal 3: 1047–1064, 2001Google Scholar
  170. 170.
    Bhat KPL, Pezzuto JM: Cancer chemopreventive activity of resveratrol. Ann NY Acad Sci 957: 210–229, 2002Google Scholar
  171. 171.
    Talalay P, Fahey IW, Holtzclaw WD, Prestera T, Zhang Y: Chemoprevention against cancer by phase II enzyme induction. Toxicol Lett 82: 173–179, 1995Google Scholar
  172. 172.
    Mukhtar H, Katiyar SK, Agarwal R: Green tea and skin-anticarcinogenic effects. J Dermatol 103: 3–7, 1994Google Scholar
  173. 173.
    Fujita Y. Uehara I, Morimoto Y, Nakashima M, Hatano T, Okuda T: Studies on inhibition of mechanism of antioxidation by tannins and flavonoids. II. Inhibition of mechanism of coffee tannins isolated from leaves of Artemisia species on lipoxigenase dependent lipid peroxidation. Yakugaku Zasshi 108: 129–135, 1988Google Scholar
  174. 174.
    Sharma S, Stutzman JD, Kelloff GJ, Steele VE: Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res 54: 5848–5855, 1994Google Scholar
  175. 175.
    Sheu S-Y, Lai C-H, Chiang H-C: Inhibition of xanthine oxidase by purpurogallin and Silymarine group. Anticancer Res 18: 263–268, 1998Google Scholar
  176. 176.
    Suh N, Luyengi L, Fong HHS, Kinghorn AD, Pezzuto JM: Discovery of natural products as chemopreventive agents utilizing HL-60 cell differentiation as a model. Anticancer Res 15: 233–240, 1995Google Scholar
  177. 177.
    Logan RF, Little J, Hawlin PG, Hardcastle JD: Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham fecal occult blood screening program. Brit Med J 307: 285–289, 1993Google Scholar
  178. 178.
    Cuendet M, Pezzuto JM: The role of cyclooxygenase and lipoxygenase in cancer research chemoprevention. Drug Metabol Drug Interact 17: 109–157, 2000Google Scholar
  179. 179.
    Lynch PM: COX-2 inhibition in clinical cancer prevention. Oncology 15(3S5): 21–26, 2001Google Scholar
  180. 180.
    Pisha E, Pezzuto JM: Cell-based assay for the determination of estrogenic and antiestrogenic activities. Meth Cell Sci 19: 37–43, 1997Google Scholar
  181. 181.
    Santen RJ, Manni A, Harvey HA: Endocrine treatment of breast cancer in women. Endocr Res 14: 1775–1778, 1990Google Scholar
  182. 182.
    Santen RJ, Harvey HA: Use of aromatase inhibitors in breast carcinoma. Endocr Relat Cancer 6: 75–92, 1999Google Scholar
  183. 183.
    Ingle JN: Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention. Oncology 15(5S7): 28–34, 2001Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Eun Jung Park
    • 1
  • John M. Pezzuto
    • 1
  1. 1.Program for Collaborative Research in Pharmaceutical Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of PharmacyUniversity of IllinoisChicagoUSA

Personalised recommendations